연구성과로 돌아가기

2021 연구성과별 연구자 정보 (737 / 2991)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Efficacy and Safety of Rebamipide versus Its New Formulation, AD-203, in Patients with Erosive Gastritis: A Randomized, Double-Blind, Active Control, Noninferiority, Multicenter, Phase 3 Study Lee, Soo Teik Lee, ST 9 Jeonbuk Natl Univ Hosp, Dept Internal Med, Jeonju, South Korea ABH-1408-2020 Lee, Si gi7pjj@korea.ac.kr;
Efficacy and Safety of Rebamipide versus Its New Formulation, AD-203, in Patients with Erosive Gastritis: A Randomized, Double-Blind, Active Control, Noninferiority, Multicenter, Phase 3 Study Kim, Ji Won Kim, JW 10 Seoul Natl Univ, SMG SNU Boramae Med Ctr, Dept Internal Med, Coll Med, Seoul, South Korea D-2733-2015 Kim, Woo gi7pjj@korea.ac.kr;
Efficacy and Safety of Rebamipide versus Its New Formulation, AD-203, in Patients with Erosive Gastritis: A Randomized, Double-Blind, Active Control, Noninferiority, Multicenter, Phase 3 Study Jeon, Han Ho Jeon, HH 11 Ilsan Hosp, Dept Internal Med, Natl Hlth Insurance Serv, Goyang, South Korea gi7pjj@korea.ac.kr;
Efficacy and Safety of Rebamipide versus Its New Formulation, AD-203, in Patients with Erosive Gastritis: A Randomized, Double-Blind, Active Control, Noninferiority, Multicenter, Phase 3 Study Chung, Il-Kwun Chung, IK 12 Soonchunhyang Univ, Dept Internal Med, Coll Med, Cheonan, South Korea gi7pjj@korea.ac.kr;
Efficacy and Safety of Rebamipide versus Its New Formulation, AD-203, in Patients with Erosive Gastritis: A Randomized, Double-Blind, Active Control, Noninferiority, Multicenter, Phase 3 Study Kim, Hyun-Soo Kim, HS 13 Chonnam Natl Univ Hosp, Dept Internal Med, Gwangju, South Korea gi7pjj@korea.ac.kr;
Efficacy and Safety of Rebamipide versus Its New Formulation, AD-203, in Patients with Erosive Gastritis: A Randomized, Double-Blind, Active Control, Noninferiority, Multicenter, Phase 3 Study Lee, Dong Ho Lee, DH 14 Seoul Natl Univ, Coll Med, Dept Internal Med, Bundang Hosp, Gwangju, South Korea J-5576-2012 Lee, Dong-Ho gi7pjj@korea.ac.kr;
Efficacy and Safety of Rebamipide versus Its New Formulation, AD-203, in Patients with Erosive Gastritis: A Randomized, Double-Blind, Active Control, Noninferiority, Multicenter, Phase 3 Study Kim, Kyoung-Oh Kim, KO 15 Gachon Univ, Dept Internal Med, Gil Med Ctr, Incheon, South Korea gi7pjj@korea.ac.kr;
Efficacy and Safety of Rebamipide versus Its New Formulation, AD-203, in Patients with Erosive Gastritis: A Randomized, Double-Blind, Active Control, Noninferiority, Multicenter, Phase 3 Study Lim, Yun Jeong Lim, YJ 16 Dongguk Univ, Dept Internal Med, Coll Med, Seoul, South Korea gi7pjj@korea.ac.kr;
Efficacy and Safety of Rebamipide versus Its New Formulation, AD-203, in Patients with Erosive Gastritis: A Randomized, Double-Blind, Active Control, Noninferiority, Multicenter, Phase 3 Study Park, Seun-Ja Park, SJ 17 Kosin Univ, Coll Med, Dept Internal Med, Gospel Hosp, Busan, South Korea gi7pjj@korea.ac.kr;
Efficacy and Safety of Rebamipide versus Its New Formulation, AD-203, in Patients with Erosive Gastritis: A Randomized, Double-Blind, Active Control, Noninferiority, Multicenter, Phase 3 Study Cho, Soo-Jeong Cho, SJ 18 Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea gi7pjj@korea.ac.kr;
Efficacy and Safety of Rebamipide versus Its New Formulation, AD-203, in Patients with Erosive Gastritis: A Randomized, Double-Blind, Active Control, Noninferiority, Multicenter, Phase 3 Study Kim, Byung-Wook Kim, BW 19 Catholic Univ Korea, Coll Med, Dept Internal Med, Incheon St Marys Hosp, Seoul, South Korea gi7pjj@korea.ac.kr;
Efficacy and Safety of Rebamipide versus Its New Formulation, AD-203, in Patients with Erosive Gastritis: A Randomized, Double-Blind, Active Control, Noninferiority, Multicenter, Phase 3 Study Ko, Kwang Hyun Ko, KH 20 CHA Univ, CHA Bundang Med Ctr, Dept Internal Med, Seongnam, South Korea gi7pjj@korea.ac.kr;
Efficacy and Safety of Rebamipide versus Its New Formulation, AD-203, in Patients with Erosive Gastritis: A Randomized, Double-Blind, Active Control, Noninferiority, Multicenter, Phase 3 Study Jeon, Seong Woo Jeon, SW 21 Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea AAU-4618-2020 Jeon, Seongwoo gi7pjj@korea.ac.kr;
Efficacy and Safety of Rebamipide versus Its New Formulation, AD-203, in Patients with Erosive Gastritis: A Randomized, Double-Blind, Active Control, Noninferiority, Multicenter, Phase 3 Study Kim, Jae Gyu Kim, JG 22 Chung Ang Univ, Dept Internal Med, Coll Med, Seoul, South Korea gi7pjj@korea.ac.kr;
Efficacy and Safety of Rebamipide versus Its New Formulation, AD-203, in Patients with Erosive Gastritis: A Randomized, Double-Blind, Active Control, Noninferiority, Multicenter, Phase 3 Study Sung, In-Kyung Sung, IK 23 Konkuk Univ, Dept Internal Med, Sch Med, Seoul, South Korea gi7pjj@korea.ac.kr;
페이지 이동: